{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:08:48Z","timestamp":1793657328483,"version":"4.5.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222038"],"award-info":[{"award-number":["82222038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202306180089"],"award-info":[{"award-number":["202306180089"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cmi.2024.11.035","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T02:45:52Z","timestamp":1733280352000},"page":"551-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Oral switch vs. continued intravenous antibiotic therapy in patients with bacteraemia and sepsis: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Qinyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaolong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daolin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2024.11.035_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cmi.2019.10.031","article-title":"Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrug-resistant pathogens","volume":"26","author":"Kern","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.035_bib2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","article-title":"Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis","volume":"28","author":"Bai","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.035_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013665","article-title":"Swiss Centre for Antibiotic Resistance (ANRESIS). Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008-2014","volume":"7","author":"Buetti","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2024.11.035_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.chest.2016.07.010","article-title":"Estimating ten-year trends in septic shock incidence and mortality in United States Academic Medical Centers using clinical data","volume":"151","author":"Kadri","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2024.11.035_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cmi.2023.04.009","article-title":"Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?","volume":"29","author":"Landersdorfer","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.035_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075297","article-title":"Sustainable practice: prescribing oral over intravenous medications","volume":"383","author":"Eii","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.11.035_bib7","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.7326\/M24-0679","article-title":"Infectious diseases: what you may have missed in 2023","volume":"177","author":"Alhammadi","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2024.11.035_bib8","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/cid\/ciw828","article-title":"Gram-positive bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group","volume":"64","author":"Doernberg","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.19.5.753","article-title":"Bacterial endocarditis in the antibiotic era","volume":"19","author":"Morgan","year":"1959","journal-title":"Circulation"},{"key":"10.1016\/j.cmi.2024.11.035_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1056\/NEJM197001222820406","article-title":"Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects","volume":"282","author":"Waldvogel","year":"1970","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2024.11.035_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","article-title":"Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial","volume":"24","author":"Kaasch","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cmi.2023.10.014","article-title":"Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial","volume":"30","author":"Omrani","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.035_bib13","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1093\/jac\/dkw129","article-title":"What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors' accounts of what influences their clinical practice","volume":"71","author":"Broom","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2024.11.035_bib14","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2023"},{"key":"10.1016\/j.cmi.2024.11.035_bib15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.11.035_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2024.11.035_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/ciy916","article-title":"Early oral switch to linezolid for low-risk patients with Staphylococcus aureus bloodstream infections: a propensity-matched cohort study","volume":"69","author":"Willekens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib18","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106736","article-title":"Uncomplicated streptococcal bacteremia: the era of oral antibiotic step-down therapy?","volume":"61","author":"Waked","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2024.11.035_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00120-23","article-title":"Comparison of oral and intravenous definitive antibiotic therapy for beta-hemolytic Streptococcus species bloodstream infections from soft tissue sources: a propensity score-matched analysis","volume":"67","author":"Yetmar","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2024.11.035_bib21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamapediatrics.2022.4123","article-title":"Short-course vs long-course antibiotic therapy for children with nonsevere community-acquired pneumonia: a systematic review and meta-analysis","volume":"176","author":"Li","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.cmi.2024.11.035_bib22","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et\u00a0al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hosp. 2000 [cited 2024 Aug 1]. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.cmi.2024.11.035_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.11.035_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.11.035_bib25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2024.11.035_bib26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/106002809603000605","article-title":"Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis","volume":"30","author":"Amodio-Groton","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cmi.2024.11.035_bib27","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/0002-9343(89)90060-0","article-title":"Randomized study of intravenous versus sequential intravenous\/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia","volume":"87","author":"Gangji","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2024.11.035_bib28","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1016\/j.ijid.2012.07.009","article-title":"A\u00a0prospective, randomized, double dummy, placebo-controlled trial of oral cefditoren pivoxil 400 mg once daily as switch therapy after intravenous ceftriaxone in the treatment of acute pyelonephritis","volume":"16","author":"Monmaturapoj","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0002-9343(91)90181-V","article-title":"Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics","volume":"91","author":"Paladino","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2024.11.035_bib30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cmi.2023.02.001","article-title":"Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis","volume":"29","author":"Diego-Yag\u00fce","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2024.11.035_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207413","article-title":"Intravenous to oral switch therapy in cancer patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus: a single-center retrospective observational study","volume":"13","author":"Itoh","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.cmi.2024.11.035_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/antibiotics9110807","article-title":"Is early oral antimicrobial switch useful for less critically ill adults with community-onset bacteraemia in emergency departments?","volume":"9","author":"Lee","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2024.11.035_bib33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jamainternmed.2018.6226","article-title":"Association of 30-day mortality with oral step-down vs continued intravenous therapy in patients hospitalized with Enterobacteriaceae bacteremia","volume":"179","author":"Tamma","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2024.11.035_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52314","article-title":"Early switch from intravenous to oral antibiotics for patients with uncomplicated gram-negative bacteremia","volume":"7","author":"Tingsg\u00e5rd","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2024.11.035_bib35","first-page":"5057","article-title":"Oral fluoroquinolones for definitive treatment of gram-negative bacteremia in cancer patients","volume":"29","author":"Tossey","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.cmi.2024.11.035_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciac714","article-title":"Outcomes of partial oral antibiotic treatment for complicated Staphylococcus aureus bacteremia in people who inject drugs","volume":"76","author":"Wildenthal","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1177\/106002809302700621","article-title":"Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials","volume":"27","author":"Cooke","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cmi.2024.11.035_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.36518\/2689-0216.1399","article-title":"Clinical impact of oral step-down therapy for gram-negative bacteremia: a retrospective study","volume":"4","author":"Nguyen","year":"2023","journal-title":"HCA Healthc J Med"},{"key":"10.1016\/j.cmi.2024.11.035_bib39","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12879-019-4280-0","article-title":"Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units","volume":"19","author":"Gasparetto","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib40","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/S1473-3099(16)30024-X","article-title":"Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines","volume":"16","author":"McMullan","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa151","article-title":"A\u00a0narrative review of early oral stepdown therapy for the treatment of uncomplicated Staphylococcus aureus bacteremia: yay or Nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjmed.2021.10.007","article-title":"Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review","volume":"135","author":"Wald-Dickler","year":"2022","journal-title":"Am J Med"},{"issue":"9 Suppl","key":"10.1016\/j.cmi.2024.11.035_bib43","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1097\/01.inf.0000086956.45566.55","article-title":"Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens","volume":"22","author":"Jantausch","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2024.11.035_bib44","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.inf.0000078160.29072.42","article-title":"Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children","volume":"22","author":"Kaplan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2024.11.035_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1086\/595686","article-title":"Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study","volume":"48","author":"Wilcox","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9 Suppl","key":"10.1016\/j.cmi.2024.11.035_bib46","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/01.inf.0000086955.93702.c7","article-title":"Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates","volume":"22","author":"Deville","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2024.11.035_bib47","article-title":"Continued intravenous versus first week transition to oral antibiotic therapy in bloodstream infections: a systematic review and meta-analysis","volume":"16","author":"Mohammed","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.cmi.2024.11.035_bib48","article-title":"Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials","author":"Mourad","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2024.11.035_bib49","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s13063-022-06495-3","article-title":"Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial","volume":"23","author":"Lee","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2024.11.035_bib50","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12913-024-11064-2","article-title":"Physicians' understanding of antibiotic intravenous-to-oral switching-a qualitative study in Suzhou, China","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cmi.2024.11.035_bib51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2016.07.013","article-title":"Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections","volume":"48","author":"Kutob","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2024.11.035_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ijantimicag.2017.12.007","article-title":"Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus \u03b2-lactams","volume":"51","author":"Mercuro","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2024.11.035_bib53","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0473","article-title":"Female sex and mortality in patients with Staphylococcus aureus bacteremia: a systematic review and meta-analysis","volume":"7","author":"Westgeest","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24005846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X24005846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:30:01Z","timestamp":1775010601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X24005846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1198743X24005846"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2024.11.035","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral switch vs. continued intravenous antibiotic therapy in patients with bacteraemia and sepsis: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2024.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.04.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}